Anika Therapeutics, Inc. - Common Stock (ANIK)

CUSIP: 035255108

Q1 2016 13F Holders as of 31 Mar 2016

Holder snapshot 7 signals
Share change
-321,661
Put/Call ratio
75%
SEC-reported price per share
$44.72
Number of holders
160
Value change
-$11,877,450
Number of buys
80
Open additional details 1 more signal available
Number of sells
65
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,404,566

Security key

035255108

Report period

Q1 2016

Institutions

160

Top holders

0

Ownership snapshot

Top reported holders of ANIK - Anika Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Archived quarter

Historical 13F summary for Q1 2016

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of ANIK - Anika Therapeutics, Inc. - Common Stock as of Q1 2016.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .